Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Julai 2026, 06:21:03

Osteomyelitis
28 Julai 2026, 06:21:03
Introduction
Osteomyelitis is an infection of the bone and bone marrow caused by pyogenic bacteria, mycobacteria, or fungi, resulting in progressive inflammatory destruction of bone, vascular compromise, bone necrosis, and reactive new bone formation. It may present as acute or chronic disease depending on the duration of symptoms. The condition can occur at any age but is most common in children younger than 12 years because of hematogenous spread to the highly vascular metaphysis of growing bones.
Staphylococcus aureus is the most common causative organism worldwide. In patients with sickle cell disease, Salmonella species are more frequently isolated than in the general population.
Epidemiology
Commonest in children younger than 12 years
Male predominance
Higher incidence among patients with diabetes mellitus
Common after open fractures and orthopaedic surgery
Increased risk in peripheral vascular disease
Increased risk in immunosuppressed patients
Common in sickle cell disease
Classification
According to duration
Acute osteomyelitis
Subacute osteomyelitis
Chronic osteomyelitis
According to route of infection
Hematogenous spread
Contiguous spread from adjacent infection
Direct inoculation following trauma or surgery
According to host status
Normal host
Compromised host (diabetes, peripheral vascular disease, immunosuppression)
Etiology
Common causative organisms
Hematogenous osteomyelitis
Staphylococcus aureus (most common)
Streptococcus species
Kingella kingae (young children)
Sickle cell disease
Salmonella species
Staphylococcus aureus
Post-traumatic or post-operative infection
Staphylococcus aureus
Coagulase-negative staphylococci
Gram-negative bacilli
Chronic osteomyelitis
Mixed aerobic and anaerobic bacteria
Specific infections
Mycobacterium tuberculosis
Fungal organisms in immunocompromised patients
Pathophysiology
Organisms enter bone through the bloodstream, contiguous spread, or direct inoculation.
Bacteria proliferate within the metaphysis, particularly in children.
Acute inflammatory response causes increased intraosseous pressure.
Blood supply becomes compromised leading to bone ischemia.
Bone necrosis results in sequestrum formation.
Reactive periosteal new bone forms an involucrum.
Chronic infection may develop with sinus tract formation.
Risk Factors
Trauma
Open fractures
Orthopaedic implants
Diabetes mellitus
Peripheral vascular disease
Sickle cell disease
Intravenous drug use
Immunosuppression
Chronic kidney disease
Recent surgery
Pressure ulcers
Clinical Presentation
Acute Osteomyelitis
Fever
Malaise
Severe localized bone pain
Fatigue
Irritability
Local swelling
Erythema
Warmth
Tenderness
Restriction of movement
Refusal to bear weight in children
Pseudoparalysis of the limb in neonates
History of recent trauma, surgery, or infection elsewhere
When infection is adjacent to a joint:
Sympathetic joint effusion
Concomitant septic arthritis
Painful limitation of joint movement
Chronic Osteomyelitis
Previous history of osteomyelitis
Recurrent pain
Persistent swelling
Erythema
Draining sinus with or without pus
Bone deformity
Low-grade fever
Recurrent exacerbations
Red Flags
Rapidly progressive swelling
Persistent high fever
Septic shock
Neurovascular compromise
Suspected compartment syndrome
Pathological fracture
Extensive soft tissue abscess
Diagnostic Criteria
The diagnosis of osteomyelitis is established through a combination of clinical assessment, laboratory investigations, imaging studies, and microbiological confirmation. A high index of suspicion is essential, particularly in children, patients with diabetes mellitus, immunocompromised individuals, and those with recent trauma or orthopaedic surgery.
A diagnosis is strongly supported by the presence of:
Major Criteria
Positive bone biopsy or bone culture demonstrating a pathogenic organism (gold standard)
Histopathological evidence of bone infection from bone biopsy
Presence of pus within bone identified during surgery or aspiration
Sinus tract communicating directly with bone
Minor Criteria
Localized bone pain or tenderness
Fever or other systemic features of infection
Local swelling, erythema, warmth, or reduced limb function
Elevated inflammatory markers (CRP and/or ESR)
Leukocytosis
Positive blood culture with a compatible clinical presentation
Imaging findings consistent with osteomyelitis (MRI, CT, bone scan, or plain radiographs)
Clinical improvement following appropriate antimicrobial therapy
Diagnosis is Considered
Definite Osteomyelitis
One or more major criteria are present.
Probable Osteomyelitis
Typical clinical features together with elevated inflammatory markers and imaging findings suggestive of osteomyelitis, particularly when supported by positive blood cultures.
Possible Osteomyelitis
Compatible clinical features with supportive laboratory or imaging findings but without microbiological confirmation. Further investigations, including bone biopsy where feasible, are recommended.
Diagnostic Principles
Bone biopsy with culture and histopathological examination remains the gold standard for confirming chronic osteomyelitis and identifying the causative organism.
Blood cultures should be obtained before initiating antibiotic therapy whenever possible.
MRI is the most sensitive imaging modality for detecting early osteomyelitis and associated soft tissue involvement.
Plain radiographs may be normal during the first 10–14 days of acute infection and should not exclude the diagnosis if clinical suspicion is high.
In chronic osteomyelitis, withholding antibiotics for approximately two weeks before bone biopsy, when clinically safe, improves microbiological yield.
Investigations
Laboratory investigations
Total and differential white blood cell count
Erythrocyte sedimentation rate (ESR)
C-reactive protein (CRP)
Blood culture and sensitivity
Urinalysis
Urine culture and sensitivity
Aspirated pus for culture and sensitivity
Bone biopsy for culture and sensitivity (gold standard in chronic disease)
For chronic osteomyelitis, antibiotics should preferably be withheld for approximately two weeks before bone biopsy whenever clinically safe to improve microbiological yield.
Special investigations
Polymerase chain reaction (PCR) for organisms such as Kingella kingae
Imaging
Plain X-ray
Ultrasound
Bone scan using Technetium-99 (especially early disease)
CT scan for complex anatomical sites such as the spine, pelvis, and shoulder
MRI (most sensitive imaging modality for early osteomyelitis where available)
Differential Diagnosis
Septic arthritis
Cellulitis
Bone tumour
Ewing sarcoma
Sickle cell vaso-occlusive crisis
Stress fracture
Osteonecrosis
Management
Management requires:
Early diagnosis
Prompt antibiotic therapy
Appropriate surgical management
Immobilization
Monitoring of inflammatory markers
Long-term follow-up
Pharmacological Treatment
Acute Osteomyelitis
Cloxacillin
1–2 g IV every 6 hours
Then continue with:
Ampicillin + Cloxacillin (fixed-dose combination)
500 mg orally every 8 hours
Continue treatment for 3–6 weeks or until CRP normalizes and radiological improvement is demonstrated.
OR
Ampicillin + Sulbactam (fixed-dose combination)
3 g IV every 6 hours for two weeks
Then:
Amoxicillin + Clavulanate (fixed-dose combination)
625 mg orally every 12 hours for four weeks.
Patients with penicillin allergy
Clindamycin
IV every 6 hours for two weeks
Then continue orally to complete 4–6 weeks
PLUS
Ciprofloxacin
400 mg IV every 12 hours for two weeks
Then continue orally to complete 4–6 weeks
Sickle Cell Disease (Salmonella suspected)
Ciprofloxacin
400 mg IV every 12 hours for four weeks
May be switched to oral therapy after two weeks if clinically improving.
Surgical Management
Acute Osteomyelitis
Surgical drainage
Bone window procedure when indicated
Recommended for patients presenting after more than 24 hours of symptoms
Drainage of abscesses
Removal of necrotic tissue
Limb immobilization
Pain control
Nutritional support
Chronic Osteomyelitis
Extensive surgical debridement
Removal of all devitalized tissue
Excision of sequestrum
Dead-space management
Antibiotic bead placement
Antibiotic cement spacer
Antibiotic cement
Vancomycin
2–4 g per 40 g of bone cement
Monitoring and Follow-up
Patients should be reviewed regularly for:
Clinical improvement
Resolution of pain
Wound healing
CRP and ESR trends
Repeat imaging when indicated
Monitoring for antibiotic toxicity
Detection of recurrence
Complications
Chronic osteomyelitis
Bone abscess
Sequestrum formation
Involucrum formation
Pathological fracture
Growth disturbance in children
Septic arthritis
Chronic draining sinus
Sepsis
Limb deformity
Amputation
Squamous cell carcinoma arising from chronic sinus tracts
Prevention
Early treatment of skin and soft tissue infections
Prompt management of open fractures
Strict aseptic surgical technique
Appropriate peri-operative antibiotics
Good glycaemic control
Early treatment of bacteraemia
Proper wound care
Patient Education
Patients should be advised to:
Complete the full antibiotic course.
Attend all follow-up appointments.
Keep wounds clean and dry.
Report persistent fever, increasing pain, or recurrent drainage immediately.
Avoid smoking where possible.
Maintain good diabetes control if diabetic.
Avoid weight bearing until medically advised.
Prognosis
The prognosis depends on the organism, duration of infection, host factors, and timing of treatment. Acute osteomyelitis treated promptly generally has an excellent outcome. Delayed diagnosis increases the risk of chronic osteomyelitis, recurrent infection, pathological fractures, and permanent disability. Chronic osteomyelitis has a higher recurrence rate and often requires repeated surgical intervention.
